Scarica l'app Stockscreener
23.64
0.30%
-0.02
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$23.66
Aprire:
$23.81
Volume 24 ore:
214.53K
Relative Volume:
0.27
Capitalizzazione di mercato:
$1.77B
Reddito:
$384.03M
Utile/perdita netta:
$38.65M
Rapporto P/E:
76.26
EPS:
0.31
Flusso di cassa netto:
$196.35M
1 W Prestazione:
+5.12%
1M Prestazione:
+21.35%
6M Prestazione:
+14.96%
1 anno Prestazione:
+30.84%
Intervallo 1D:
$23.35
$23.86
Intervallo di 1 settimana:
$22.12
$24.01
Portata 52W:
$16.52
$24.01
Innoviva Inc Stock (INVA) Company Profile
Nome
Innoviva Inc
Settore
Industria
Telefono
(650) 238-9600
Indirizzo
1350 OLD BAYSHORE HIGHWAY, BURLINGAME
Compare INVA vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
INVA
Innoviva Inc
|
23.63 | 1.77B | 384.03M | 38.65M | 196.35M | 0.31 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.28 | 119.47B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
779.47 | 83.75B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
845.39 | 52.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
337.17 | 44.12B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
355.93 | 39.73B | 4.98B | 69.60M | 525.67M | 0.5198 |
Innoviva Inc Stock (INVA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-30 | Iniziato | Goldman | Sell |
| 2025-08-11 | Iniziato | Oppenheimer | Outperform |
| 2025-07-14 | Iniziato | H.C. Wainwright | Buy |
| 2025-07-11 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-03-07 | Iniziato | Scotiabank | Sector Outperform |
| 2024-06-18 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-07-20 | Iniziato | Goldman | Neutral |
| 2017-11-20 | Iniziato | Deutsche Bank | Hold |
Mostra tutto
Innoviva Inc Borsa (INVA) Ultime notizie
Innoviva to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference - Business Wire
BTIG Research Begins Coverage on Innoviva (NASDAQ:INVA) - Defense World
Innoviva, Inc. (INVA) Stock Analysis: Potential 43% Upside Captivates Investors - DirectorsTalk Interviews
Innoviva stock gains BTIG coverage with buy rating on royalty windfall - Investing.com
BTIG Initiates Innoviva at Buy With $35 Price Target - marketscreener.com
BTIG Initiates Coverage on Innoviva (INVA) with a 'Buy' Rating | - GuruFocus
BTIG Initiates Coverage of Innoviva (INVA) with Buy Recommendation - Nasdaq
Will Innoviva Inc. outperform tech stocksJuly 2025 Action & Verified Technical Trade Signals - mfd.ru
(INVA) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Earnings Miss: What is the next catalyst for Innoviva Inc.2025 Investor Takeaways & Technical Pattern Alert System - mfd.ru
Innoviva stock hits 52-week high at $22.81 By Investing.com - Investing.com Nigeria
Innoviva's Financial Metrics Show Resilience Amid Long-Term Growth Challenges - Markets Mojo
Innoviva (NASDAQ:INVA) Sets New 52-Week HighShould You Buy? - MarketBeat
Is Innoviva Inc. likely to announce a buybackQuarterly Earnings Summary & Weekly Hot Stock Watchlists - mfd.ru
Innoviva stock hits 52-week high at $22.81 - Investing.com
Panic Selling: What is the next catalyst for Innoviva IncWeekly Risk Summary & Verified Momentum Watchlists - baoquankhu1.vn
Resistance Check: Is Innoviva Inc affected by consumer sentiment2025 Analyst Calls & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
New York State Common Retirement Fund Decreases Stock Holdings in Innoviva, Inc. $INVA - MarketBeat
Allianz Asset Management GmbH Has $3.59 Million Holdings in Innoviva, Inc. $INVA - MarketBeat
Innoviva, Inc. (INVA) Stock Analysis: Exploring A 50% Potential Upside For Investors - DirectorsTalk Interviews
Tetracyclines Market is Poised to Garner Valuation of USD 5.63 Billion by 2035 | Astute Analytica - GlobeNewswire Inc.
Innoviva Inc (NASDAQ:INVA) Presents a Compelling Value Investment Case - ChartMill
33,280 Shares in Innoviva, Inc. $INVA Acquired by Y Intercept Hong Kong Ltd - Defense World
Liquidity Mapping Around (INVA) Price Events - Stock Traders Daily
Innoviva, Inc.'s (NASDAQ:INVA) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects? - 富途牛牛
Innoviva, Inc. (NASDAQ:INVA) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Innoviva, Inc. (NASDAQ:INVA) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Universal Beteiligungs und Servicegesellschaft mbH Increases Stock Position in Innoviva, Inc. $INVA - MarketBeat
Hedge Fund Bets: Is Innoviva Inc impacted by rising ratesMarket Activity Recap & Real-Time Volume Spike Alerts - baoquankhu1.vn
Hussman Strategic Advisors Inc. Sells 168,000 Shares of Innoviva, Inc. $INVA - MarketBeat
Investing in Innoviva (NASDAQ:INVA) five years ago would have delivered you a 57% gain - Yahoo Finance
Innoviva (NASDAQ:INVA) Share Price Passes Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
Armata Extends Innoviva Credit, Warrants and Voting Pact - The Globe and Mail
Will Innoviva Inc. benefit from rate cutsTreasury Yields & Risk Managed Investment Strategies - mfd.ru
Downgrade Watch: Will Innoviva Inc outperform tech stocksTrade Risk Summary & Verified Momentum Watchlists - baoquankhu1.vn
Why (INVA) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Street Watch: What is the next catalyst for Innoviva IncInflation Watch & Stock Portfolio Risk Control - baoquankhu1.vn
The Truth About Innoviva Inc: Why Everyone Is Suddenly Watching This ‘Boring’ Stock - AD HOC NEWS
Death Cross: Is Innoviva Inc affected by consumer sentiment2025 Market WrapUp & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Cantor Fitzgerald Maintains and Raises Price Target for INVA | I - GuruFocus
Innoviva (NASDAQ:INVA) Shares Cross Above Two Hundred Day Moving Average – Here’s What Happened - Defense World
Innoviva (NASDAQ:INVA) Shares Cross Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
Innoviva, Inc. (INVA) Stock Analysis: Exploring a 67% Potential Upside in the Biotechnology Sector - DirectorsTalk Interviews
Understanding Momentum Shifts in (INVA) - Stock Traders Daily
Innoviva (INVA) price target decreased by 12.36% to 32.90 - MSN
Can Innoviva Inc. stock beat market expectations this quarterStability vs Neutral Overview & support options for steady strides - Улправда
Innoviva, Inc.Common Stock (NQ: INVA - FinancialContent
Volume Recap: Can Innoviva Inc. stock beat market expectations this quarterJuly 2025 Review & Safe Capital Growth Tips - Улправда
Is Innoviva Inc. stock positioned for digital transformationOil Prices & High Return Trade Guides - Улправда
Is Innoviva Inc. stock in correction or buying zoneJuly 2025 Macro Moves & Weekly Setup with ROI Potential - ulpravda.ru
Los Angeles Daily NewsInnoviva, Inc.Common Stock (Nasdaq:INVA) Detailed Stock Data - FinancialContent
Innoviva Inc Azioni (INVA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.40%
1.49%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):